drugset / Trial / NCT00292838
Relative Potency of Inhaled Corticosteroids
RandomizedCrossoverDouble-blindTreatment
Summary
To investigate the validity of a clinical model to determine the relative potency of different preparations of inhaled corticosteroids used for the treatment of asthma or of eosinophilic bronchitis without asthma.
Timeline
- Start
- 2001-01
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 25 ug | Inhaled |
| Subject | Fluticasone | Other / unclassified | 50 ug | Inhaled |
| Subject | Fluticasone | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone | Other / unclassified | 200 ug | Inhaled |